British Columbia source: bounded use
Workup of Microscopic Hematuria supplies a Canadian implementation example for this summary. It must not be presented as the rule outside British Columbia.
sources for this section:BC hematuria
Source-attributed clinical priorities
- Confirm blood with urinalysis and distinguish glomerular, infectious, stone, traumatic and urologic cancer features.
- Do not dismiss hematuria solely because the patient takes anticoagulants; evaluate according to malignancy and renal risk.
- Use the local urology and nephrology referral pathways, escalating clots with retention, sepsis or acute kidney injury.
- Repeat a properly collected urine sample and assess microscopy and protein when glomerular disease is possible.
sources for this section:BC hematuria
Practical assessment and management workflow
1
Confirm visible versus microscopic blood and ask about infection, stones, exercise, menstruation, trauma and anticoagulants.
2
Check blood pressure, kidney function, urinalysis and culture and assess malignancy risk.
3
Use risk-directed imaging and cystoscopy through the Canadian urology pathway.
4
Track completion and refer nephrology when proteinuria, casts or impaired kidney function suggests renal disease.
sources for this section:BC hematuria
Safety, red flags and urgent escalation
- Clot retention, anuria, sepsis or unstable bleeding needs emergency urologic care.
- Do not dismiss hematuria because the patient is anticoagulated.
- Persistent visible hematuria requires evaluation even after an apparent UTI resolves.
sources for this section:BC hematuria
Confirm the local pathway before acting
British Columbia is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient鈥檚 province or territory.
sources for this section:BC hematuria
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:BC hematuria
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Government of British ColumbiaWorkup of Microscopic Hematuriaaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.